SCHEMBL7305713

SCHEMBL7305713

CCOC(=O)CC1(C(=O)OCC)CCN(CC2CN(CCCCN3CCN(C(=N)N)CC3)C(=O)O2)CC1

nearest known ligand 0.37

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 1/20 0.37
ITGA2B P08514 1/20 0.37
GAA P10253 1/20 0.32
ALDH1A1 P00352 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
POLB P06746 1/20 0.31
HTT P42858 1/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
HRH2 P25021 1/20 0.31
HRH1 P35367 1/20 0.31
KCNA3 P22001 1/20 0.31
SIGMAR1 Q99720 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7314498 0.98 ITGB3 (0.37) ITGB3ITGA2BGAAALDH1A1L3MBTL1
SCHEMBL7308973 0.95 ITGB3 (0.38) ITGB3ITGA2BKDM4EMEN1KMT2A
SCHEMBL7310379 0.91 ITGB3 (0.37) ITGB3ITGA2BALDH1A1L3MBTL1POLB
SCHEMBL7304312 0.90 KCNH2 (0.34) ITGB3ITGA2BGAAALDH1A1POLB
SCHEMBL7316892 0.90 ITGB3 (0.37) ITGB3ITGA2BGAAALDH1A1L3MBTL1
SCHEMBL7307496 0.90 KCNH2 (0.36) ITGB3ITGA2BGAAALDH1A1POLB
SCHEMBL7316734 0.88 KCNH2 (0.37) ITGB3ITGA2BGAAALDH1A1POLB
SCHEMBL7306954 0.86 KCNH2 (0.37) ITGB3ITGA2BGAAPOLBKDM4E
SCHEMBL7313324 0.86 ITGB3 (0.32) ITGB3ITGA2BSIGMAR1
SCHEMBL8858192 0.86 ITGB3 (0.34) ITGB3ITGA2BGAAALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5627197-A Adhesion receptor antagonists MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1997-05-06 US disclosed
EP-0727425-A1 Adhesion receptor antagonists MERCK PATENT GmbH (DE) 1996-08-21 EP disclosed